Distribution: Public Hospitals Subject:

First Page		Document Content
Date: 2015-03-18 23:30:43 Chemistry Organic chemistry Ribavirin Interferon Hepatitis B Lopinavir Peginterferon alfa-2b PEGylation Nelfinavir Pharmacology Antivirals Protease inhibitors		Distribution: Public Hospitals Subject: Add to Reading List Source URL: www.health.vic.gov.au Download Document from Source Website File Size: 19,18 KB Share Document on Facebook

	ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr DocID: 1uHNe - View Document
	Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 DocID: 1rrGr - View Document
	Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 DocID: 1rrm1 - View Document
	Microsoft Word - Savient Press Release ACRdoc DocID: 1rrcY - View Document
	Microsoft Word - Savient Phase 3 Dosing press releasedoc DocID: 1ri7E - View Document